ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 578,13
-0,72%
Dow Jones
40 211,72
0,00%
DAX
18 499,65
-0,54%
Brent Oil
82,875
-1,74%
Bitcoin
63 786,30
-1,64%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Hutchison China Meditech Ltd (0J7G)

  7. Hutchison China Meditech Ltd (0J7G) Actualités

0J7G

Hutchison China Meditech (0J7G)

Hutchison China Meditech Ltd
De:
Trier par:
 Showing the most relevant articles for your search:LSE:0J7G
DateHeureSourceTitreSymboleSociété
09/08/202210h30RNS Non-RegulatoryHutchmed (China) Limited First Participant in Phase I Trial of IMG-004LSE:0J7GHutchison China Meditech Ltd
08/08/202210h30RNS Non-RegulatoryHutchmed (China) Limited Preliminary results from SAVANNAH Phase 2 TrialLSE:0J7GHutchison China Meditech Ltd
08/08/202208h00UK RegulatoryHutchmed (China) Limited FRESCO-2 Study Has Met Primary EndpointLSE:0J7GHutchison China Meditech Ltd
01/08/202213h04UK RegulatoryHutchmed (China) Limited Interim Results and Business UpdatesLSE:0J7GHutchison China Meditech Ltd
01/08/202208h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Initiates Bridging Study of TazemetostatLSE:0J7GHutchison China Meditech Ltd
15/07/202210h30RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Initiates Phase I Trial of HMPL-A83LSE:0J7GHutchison China Meditech Ltd
13/07/202208h00RNS Non-RegulatoryHutchmed (China) Limited Results of SAVANNAH Global Phase II Trial at WCLCLSE:0J7GHutchison China Meditech Ltd
06/07/202208h00RNS Non-RegulatoryHutchmed (China) Limited First Participants in Phase I Trial of IMG-007LSE:0J7GHutchison China Meditech Ltd
30/06/202210h30UK RegulatoryHutchmed (China) Limited Total Voting RightsLSE:0J7GHutchison China Meditech Ltd
29/06/202210h30UK RegulatoryHutchmed (China) Limited Blocklisting Six Monthly ReturnLSE:0J7GHutchison China Meditech Ltd
27/06/202210h30UK RegulatoryHutchmed (China) Limited HUTCHMED to Announce 2022 Half-Year ResultsLSE:0J7GHutchison China Meditech Ltd
01/06/202210h30RNS Non-RegulatoryHutchmed (China) Limited TAZVERIK(R) Approved in Hainan Pilot ZoneLSE:0J7GHutchison China Meditech Ltd
24/05/202212h00UK RegulatoryHutchmed (China) Limited LTIP and Share OptionsLSE:0J7GHutchison China Meditech Ltd
16/05/202213h00UK RegulatoryHutchmed (China) Limited Appointment of Non--Executive DirectorLSE:0J7GHutchison China Meditech Ltd
03/05/202208h01UK RegulatoryHutchmed (China) Limited HUTCHMED Receives CRL from the US FDALSE:0J7GHutchison China Meditech Ltd
27/04/202215h30UK RegulatoryHutchmed (China) Limited Annual General Meeting Poll ResultsLSE:0J7GHutchison China Meditech Ltd
21/04/202210h30UK RegulatoryHutchmed (China) Limited Vesting of awards under Long Term Incentive PlanLSE:0J7GHutchison China Meditech Ltd
31/03/202208h01UK RegulatoryHutchmed (China) Limited Update on Status under HFCAALSE:0J7GHutchison China Meditech Ltd
23/03/202209h30UK RegulatoryHutchmed (China) Limited 2021 Annual Report and Notice of AGMLSE:0J7GHutchison China Meditech Ltd
07/03/202208h01RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Receives $15m Milestone from AstraZenecaLSE:0J7GHutchison China Meditech Ltd
03/03/202216h30RNS Non-RegulatoryHutchmed (China) Limited Publication of Form 20-FLSE:0J7GHutchison China Meditech Ltd
03/03/202213h30UK RegulatoryHutchmed (China) Limited Retirement of CEO and appointment of new CEOLSE:0J7GHutchison China Meditech Ltd
03/03/202213h00UK RegulatoryHutchmed (China) Limited Full Year Results and Business UpdatesLSE:0J7GHutchison China Meditech Ltd
01/03/202209h30RNS Non-RegulatoryHutchmed (China) Limited Approval to Commercialize ELUNATE(R) in MacauLSE:0J7GHutchison China Meditech Ltd
07/02/202209h29UK RegulatoryHutchmed (China) Limited HUTCHMED to Announce 2021 Final ResultsLSE:0J7GHutchison China Meditech Ltd
04/02/202210h29RNS Non-RegulatoryHutchmed (China) Limited Phase Ib/II Combination Study of HMPL-453LSE:0J7GHutchison China Meditech Ltd
20/01/202208h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Initiates Phase I Trial of HMPL-653LSE:0J7GHutchison China Meditech Ltd
19/01/202208h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Data at ASCO GI Cancers SymposiumLSE:0J7GHutchison China Meditech Ltd
17/01/202210h00UK RegulatoryHutchmed (China) Limited Holding(s) in CompanyLSE:0J7GHutchison China Meditech Ltd
12/01/202212h00RNS Non-RegulatoryHutchmed (China) Limited Breakthrough Therapy Designation for HMPL-523LSE:0J7GHutchison China Meditech Ltd
 Showing the most relevant articles for your search:LSE:0J7G

Dernières Valeurs Consultées

LSE
ATST
Alliance
ASX
ASMO
Australian Strategic Mat...
NASDAQ
CTRN
Citi Trends
NASDAQ
NNAGU
99 Acquisition
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés